Drug intelligence / Profile preview

N-methylmesoporphyrin

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-methylmesoporphyrin (NMM) is a synthetic porphyrin derivative and a member of the porphyrins class. It is primarily used as an experimental tool in research settings. Mechanistically it acts as a potent inhibitor of ferrochelatase—the enzyme responsible for catalyzing the insertion of iron into protoporphyrin IX during heme biosynthesis[1][4]. Additionally, NMM exhibits high selectivity for binding to G-quadruplex DNA structures over duplex or triplex DNA. Upon binding to G-quadruplexes (notably in telomeric and oncogene promoter regions), it stabilizes these structures and becomes highly fluorescent—making it valuable as a fluorescent probe for studying nucleic acid conformations and interactions[5][8]. Its applications include cancer research (due to its effects on gene expression via GQ stabilization), diagnostics (as a light-up probe), and studies on heme metabolism inhibition[5][9]. It is not approved for clinical use in humans.

Other names
8,13-diethyl-3,7,12,17,23-pentamethyl-21H,23H-porphine-2,18-dipropanoic acid3-[18-(2-carboxyethyl)-7,12-diethyl-3,8,13,17,22-pentamethyl-23H-porphyrin-2-yl]propanoic acidSCHEMBL13325428SCHEMBL-13325428SCHEMBL 13325428SCHEMBL18428599SCHEMBL-18428599SCHEMBL 18428599DTXSID70349630DTXSID-70349630DTXSID 70349630
02

Targets

G4 (G-quadruplex DNA)FECH (Ferrochelatase)

Beyond the preview

Go deeper on N-methylmesoporphyrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-methylmesoporphyrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call